LAC 46:XLV.6119. Informed Consent

A. In addition to the written release and authorization set forth in Section 6115.E, a MP shall insure that each of his or her patients subject to consultation and collaboration with a physician is informed: 1. of the relationship between the MP and physician and the respective role of each with respect to the patient’s psychopharmacologic management; 2. that he or she may decline to participate in such a practice and may withdraw at any time without terminating the MP-patient relationship; 3. of the MP’s decision to withdraw from consultation and collaboration with a physician; and 4. by written disclosure, of any contractual or financial arrangement that may impact the MP’s decision to engage in consultation and collaboration with a physician.